Lappaconitine: Influence of Halogen Substituent on the Antiarrhythmic Activity

ISSN: 1875-6182 (Online)
ISSN: 1871-5257 (Print)

Volume 13, 2 Issues, 2015

Download PDF Flyer

Cardiovascular & Hematological Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Cardiovascular & Hematological Agents

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Debabrata Mukherjee
Department of Internal Medicine Texas Tech University
4800 Alberta Avenue El Paso
Texas, 79905

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Lappaconitine: Influence of Halogen Substituent on the Antiarrhythmic Activity

Cardiovascular & Hematological Agents in Medicinal Chemistry, 11(3): 211-217.

Author(s): A. O. Bryzgalov, V. E. Romanov, T. G. Tolstikova and E E Shults.

Affiliation: Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9 Prosp. Akad. Lavrent`eva, 630090 Novosibirsk, Russian Federation.


The current paper presents research results related to antiarrhythmic activity of halogen-containing derivatives of lappaconitine. Lappaconitine derivatives with iodine, chlorine or bromine substituting the anthranilate moiety at C-5` position were shown in vivo and in vitro to exhibit a more (Br, I) or less (Cl) pronounced antiarrhythmic activity in the models of calcium chloride- and adrenaline-induced arrhythmias as compared with the reference compound lappaconitine. The intensity of antiarrhythmic action depending on halogen substituent was found to be expressed by the following order: Cl < I < Br.


Arrhythmia, lappaconitine, halogen-containing lappaconitine derivatives.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 11
Issue Number: 3
First Page: 211
Last Page: 217
Page Count: 7
DOI: 10.2174/18715257113119990083

Related Journals

Webmaster Contact: Copyright © 2015 Bentham Science